Medtronic Australasia Pty Ltd.
97 Waterloo Road North Ryde, NSW 2113
Phone: 1800 777 808

10 things to know about CGM reimbursement in Australia

Friday, October 2, 2015 - 16:49

  1. We are asking the Australian Federal Government for a commitment of $4.4 Million this current financial year to potentially save 1,537 lives from the devastating consequences of type 1 diabetes.
  2. The Government recognises diabetes as a National Health Priority Area and is a stakeholder in current CGM sensor research.
  3. The Government has been asked to fund CGM (continuous glucose monitoring) sensors on the NDSS for a limited subgroup of vulnerable patients with type 1 diabetes who have impaired awareness of low glucose levels (i.e. they are “hypo unaware”).
  4. People who are hypo unaware are six times more likely to have severe hypoglycaemia leading to seizures, coma and even death. Having hypos leads to more hypos and the increased risk of these severe events.
  5. The cost to treat an individual for type 1 diabetes-related complications is much higher than the incremental annual cost of CGM sensors for that patient.
  6. Clinical studies, including Australian research by Ly et al shows CGM sensors combined with an insulin pump that automatically stops insulin delivery when glucose levels go too low, may prevent seizures, comas and death.
  7. Government has confirmed the clinical and cost-effectiveness of CGM used with an insulin pump but still have not funded this therapy despite significant community pressure.
  8. CGM sensors used with an insulin pump that automatically stops insulin delivery when glucose levels go too low, have been shown to be cost-effective (read this Value in Health publication):
  9. Without a Committee to make recommendations for listing new technologies on the NDSS, a decision regarding the funding of CGM sensors is required by the Health Minister
  10. The NDSS investment for hypo-unaware patients at high risk of seizures, coma and potential death to have subsidised access to CGM sensors is based on the following budget estimates. 

 

Year 1

Year 2

Year 3

Year 4

Year 5

Year

2015-16

2016-17

2017-18

2018-19

2019-20

Patient number

1,537

2,052

2,500

2,787

2,934

NDSS Investment

$4.40M

$5.87M

$7.15M

$7.97M

$8.39M

Rallying your MP

You can share your story by emailing your MP using the template below. Simply insert your story and encourage them to take action by supporting sensor funding on the NDSS.

Share your story and take action by following the three easy steps below. We’ve included an example within the template below from a MiniMed Ambassador, Ros.

Step 1:
Find your MP’s email address here. http://www.aph.gov.au/Senators_and_Members/Members 

(Note: If their address details aren't there, send the email below to department@treasury.gov.au)

Step 2:

Open the email and paste in your MP’s email address.

Step 3:

Add your own #SmartGuardStories about how CGM has changed your life. Then hit send!

Open Email Here